Κατηγορία: Άρθρα

Venous Thromboembolism in Patients with Lung Cancer

Considering the high prevalence of lung cancer, our purpose was to summarize the existing literature to identify the several factors that contribute to the increased risk of venous thromboembolism (VTE) in patients with lung cancer and to analyze the current recommendations for thromboprophylaxis and treatment of VTE in those patients. Methods: We searched the Medline […]

CONTINUE READING Venous Thromboembolism in Patients with Lung Cancer

Anaphylaxis during rapid oral desensitization to rifampicin

Rifampicin (also known as rifampin) is one of the most potent first-line antituberculosis drugs and an indispensable treatment option for isoniazid-resistant, rifampicin-sensitive tuberculosis (TB). Hypersensitivity reactions to rifampicin, mainly including fever, flu-like syndrome, rash, thrombocytopenia, acute renal failure, urticaria, and anaphylaxis, are considered rare but may occur among susceptible individuals and lead to premature discontinuation […]

CONTINUE READING Anaphylaxis during rapid oral desensitization to rifampicin

Giant Tuberculin Reaction Associated With the Homeopathic Drug Tuberculinum: A Case Report

The tuberculin skin test (TST) is the most widely used screening tool for the detection of latent tuberculosis. Skin reaction to intradermal injection of tuberculin, a purified protein derivative (PPD) of tubercle bacilli, is based on the induction of a delayed- type hypersensitivity response in subjects presensitized to mycobacterial antigens [1]. According to the latest […]

CONTINUE READING Giant Tuberculin Reaction Associated With the Homeopathic Drug Tuberculinum: A Case Report

Levels of Vascular Endothelial Growth Factor in Serum and Pleural Fluid are Independent Predictors of Survival in advanced NSCLC: Results of a Prospective Study

Aim: To further evaluate the prognostic significance of pretreatment serum and pleural fluid levels of vascular endothelial growth factor VEGF in patients with non-small cell lung cancer (NSCLC) presenting with malignant pleural effusion (MPE). Patients and Methods: Forty consecutive newly diagnosed patients with NSCLC with MPE at presentation but without distant metastases were prospectively enrolled. […]

CONTINUE READING Levels of Vascular Endothelial Growth Factor in Serum and Pleural Fluid are Independent Predictors of Survival in advanced NSCLC: Results of a Prospective Study

Clinical Significance of Smoking Cessation in Patients With Cancer: A 30-Year Review

Despite the established causal relationship between tobacco smoking and cancer, many cancer patients continue to smoke after diagnosis. This partly reflects ignorance of the beneficial effects of smoking cessation, even after diagnosis. The aim of this study was to demonstrate the effects of continuing or quitting smoking in patients with diagnosed cancer. METHODS: The study […]

CONTINUE READING Clinical Significance of Smoking Cessation in Patients With Cancer: A 30-Year Review

The Intercellular Cell Adhesion Molecule-1 (ICAM-1) in Lung Cancer: Implications for Disease Progression and Prognosis

Abstract. The intercellular cell-adhesion molecule-1 (ICAM-1) is a transmembrane molecule and a distinguished member of the Immunoglobulin superfamily of proteins that participates in many important processes, including leukocyte endothelial transmigration, cell signaling, cell-cell interaction, cell polarity and tissue stability. ICAM-1and its soluble part are highly expressed in inflammatory conditions, chronic diseases and a number of […]

CONTINUE READING The Intercellular Cell Adhesion Molecule-1 (ICAM-1) in Lung Cancer: Implications for Disease Progression and Prognosis

Developments in the Treatment of Non-small Cell Lung Cancer

Lung cancer remains the leading cause of cancerrelated deaths among men and women in the civilized world. Although there have been major improvements over the recent decades in surgical techniques and the role of chemotherapyradiotherapy in the treatment of non-small cell lung cancer (NSCLC), the long-term outlook for these patients has not changed significantly. The […]

CONTINUE READING Developments in the Treatment of Non-small Cell Lung Cancer

Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study

Background: The aim of this study was to determine the progression-free survival (PFS) and toxicity associated with adjuvant administration of carboplatin and pemetrexed for completely resected patients with stage IB, II and IIIA non-small cell lung cancer (NSCLC). Patients and Methods: Forty-five eligible NSCLC patients received surgical resection for pathological stage IB, II or IIIA […]

CONTINUE READING Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study

Docetaxel plus Gemcitabine as First-line Treatment in Mlignant Pleural Mesothelioma: A Single Institution Phase II Study

Background: The cisplatin-pemetrexed and cisplatin-gemcitabine combinations are considered the standard treatment for malignant pleural mesothelioma. The purpose of this study was to examine the efficacy of gemcitabine plus docetaxel in the first-line setting, as this combination has not been investigated in mesothelioma before. Patients and Methods: Twenty-five consecutive patients with malignant pleural mesothelioma were enrolled. […]

CONTINUE READING Docetaxel plus Gemcitabine as First-line Treatment in Mlignant Pleural Mesothelioma: A Single Institution Phase II Study

Sampling versus systematic full lymphatic dissection in surgical treatment of non-small cell lung cancer

The extent of mediastinal lymph node assessment during surgery for non-small cell cancer remains controversial. Different techniques are used, ranging from simple visual inspection of the unopened mediastinum to an extended bilateral lymph node dissection. Furthermore, different terms are used to define these techniques. Sampling is the removal of one or more lymph nodes under […]

CONTINUE READING Sampling versus systematic full lymphatic dissection in surgical treatment of non-small cell lung cancer
TOP
Τρόποι Πληρωμής
  • Αντικαταβολή
  • Πληρωμή με κάρτα
  • Paypal
  • Τραπεζική Κατάθεση